Anders Jack 4
4 · Revolution Medicines, Inc. · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Anders Jack
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-07$42.45/sh+10,000$424,500→ 118,065 total - Sale
Common Stock
2026-01-07$98.00/sh−10,000$980,000→ 108,065 total - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-07−10,000→ 15,900 totalExercise: $42.45From: 2025-03-04Exp: 2031-03-03→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.
- [F2]Includes 42,338 restricted stock units.